Zobrazeno 1 - 10
of 109
pro vyhledávání: '"W, Niklinska"'
Autor:
J., Pancewicz1 jpancewicz@ymail.com, W., Niklinska1
Publikováno v:
Progress in Health Sciences. 2021, Vol. 11 Issue 2, p141-144. 4p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lech Chyczewski, E Chyczewska, M Furman, J Niklinski, Jerzy Laudanski, M R Rusin, W Niklinska, Tomasz Burzykowski, M Sulik
Publikováno v:
European Journal of Cancer Prevention. 9:81-88
We investigated the association of p53 abnormalities (gene mutations by DNA sequencing and protein over-expression by immunostaining) with clinical data and prognosis in 74 patients with resected non-small cell lung cancer (NSCLC). DNA analysis of ex
Publikováno v:
Neoplasma. 49(3)
Considering the particular importance of angiogenesis and tumor suppressor genes expression in solid tumors, angiogenesis and Bcl-2 protein expression were evaluated in order to specify their role in the biology of endometrial carcinoma. Clinical mat
Publikováno v:
Folia histochemica et cytobiologica. 39
We investigated the clinical significance of p16 abnormalities (mutations by sequencing and hypermethylation by methylation-specific PCR) in 52 radically resected stage I-II non-small cell lung cancers (NSCLCs). P16 abnormalities were detected in 20
Publikováno v:
Folia histochemica et cytobiologica. 39
Activated point mutations of the K-ras gene are one of the most common genetic alterations found in human malignancies, including lung cancer, and are largely limited to adenocarcinomas. Using a highly sensitive assay for codon 12 K-ras mutation dete
G1 phase of the cell cycle control and lung cancer: biological and clinical implications. Minireview
Publikováno v:
Neoplasma. 48(3)
Neoplastic diseases, including lung cancer are characterized by an uncoordinated cell growth. Cellular proliferation follows an orderly progression through the cell cycle, which is governed by protein complexes composed of cyclins and cyclin-dependen
Publikováno v:
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 10(3)
Lung cancer is a leading cause of cancer death worldwide; however, despite major advances in cancer treatment during the past two decades, the prognostic outcome of lung cancer patients has improved only minimally. This is largely due to the inadequa
Publikováno v:
Folia histochemica et cytobiologica. 39(2)
We assessed the status of P53 in 32 surgically treated non-small cell lung cancers (NSCLC) by using yeast functional assay. For functional assay, total RNA extracted from fresh-frozen specimens was reverse transcribed and P53 cDNAs were PCR-amplified